United Kingdom · Question · Written question
HL HL517
Pancreatic Cancer: Daraxonrasib
Introduced
1 June 2026
Last action
—
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
10 June 2026
Summary
To ask His Majesty's Government what assessment they have made of the potential for the drug Daraxonrasib to treat advanced pancreatic cancer; and when they expect the National Institute for Health and Care to complete their technology appraisal of the dr
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.